Antitrust Body Probing Teva Over Distribution Firm

Investigation launched after Teva investor complained about the potential for price-fixing via its subsidiary, S.L.E.

Ora Coren
Ora Coren
Send in e-mailSend in e-mail
Teva Pharmaceutical, Oct.30, 2013.

Comments